Bone grafting is a surgical procedure that replaces the missing or damaged bone by natural or synthetic bone. There are three major types of bone grafts: autografts, allografts, and bone substitutes. Modern bone grafts, bone grafts substitutes and bioactive factors enhance the natural healing process via osteoinductive, osteoconductive and osteogenic mechanisms in suboptimal conditions. Autologous, allogenic and synthetic substrates contribute to modern fracture care and bone loss. Bone grafts and bone grafts substitutes should be biocompatible, osteoconductive, osteoinductive, structurally similar to bone, easy to use, and cost effective. Autogenous bone grafts contain osteoblast and endosteal osteoprogenitor cells for regenerating the new bone, while limited supply and high donor site morbidity rate are major disadvantages associated with it.
The global bone grafts and bone grafts substitutes market report provides market size estimates (Revenue USD million – 2014 to 2021) for key market segments based on product type (demineralized bone matrix allografts, and bone graft substitutes – bone morphogenic proteins and synthetic bone graft extenders) and its medical applications (craniomaxilofacial, dental, foot and ankle, joint reconstruction, long bone, and spinal fusion), and forecasts growth trends (CAGR% – 2017 to 2021).
The global bone grafts and bone grafts substitutes market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global bone grafts and bone grafts substitutes market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global bone grafts and bone grafts substitutes market and included in this report are DePuy Synthes Companies, Zimmer Biomet Holdings, Inc., Baxter International, Inc., Medtronic plc, Stryker Corporation, Wright Medical Technology Inc., AlloSource, NuVasive Inc., and Orthofix Holdings, Inc.